Medison Pharma announces multi-regional agreement with argenx to commercialize Efgartigimod
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology
Researchers presented these bladder cancer study findings at the 117th Annual Scientific Meeting of the American Urological Association (AUA)
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases
A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris
The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective
Subscribe To Our Newsletter & Stay Updated